ID   EC [Human ovarian yolk sac tumor]
AC   CVCL_W130
DR   Wikidata; Q54831776
RX   DOI=10.1063/1.1291135;
RX   PubMed=8718548;
RX   PubMed=15677628;
RX   PubMed=21597681;
CC   Population: Japanese.
CC   Doubling time: 36.1 hours (PubMed=21597681).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.1063/1.1291135;
RA   Kiyozuka Y., Takemoto K., Yamamoto A., Guttmann P., Tsubura A.,
RA   Kihara H.;
RT   "X-ray microimaging of cisplatin distribution in ovarian cancer
RT   cells.";
RL   AIP Conf. Proc. 507:153-153(2000).
//
RX   PubMed=8718548;
RA   Murakami F.;
RT   "Cytotoxic action of monoclonal antibodies OC125 and SH-9 on ovarian
RT   cancer cell lines.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 48:125-132(1996).
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C.,
RA   Edwards P.A.W., Caldas C.;
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//
RX   PubMed=21597681; DOI=10.3892/or.2.1.17;
RA   Imamura K., Kiyozuka Y., Nishimura H., Yakushiji M.;
RT   "Novel germ-cell tumor-cell line established from a testicular
RT   feminization syndrome.";
RL   Oncol. Rep. 2:17-25(1995).
//